If you've been dying to get a look at a Polonator, Keith Robison has a picture of one on his blog. Robison got a look at it at the CHI Next-Gen meeting last month and he says that "the truly intriguing angle on the Polonator is that it is a completely open architecture." He adds that is "pretty enticing from a techie angle, but it's also a pretty risky business strategy." He's also thinking about what projects he could do if he were to have a Polonator.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.